Results

Total Results: 179 records

Showing results for "corporation".

1. Peripheral-Artery-Disease-Treatment Research-Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
   January 31, 2013 - Corporation FDA approved Coyote ES Standard Boston Scientific Corporation FDA approved Sterling … Standard Boston Scientific Corporation FDA approved Mustang Standard Boston Scientific Corporation … Scientific Corporation FDA approved Blue Max 20 Standard Boston Scientific Corporation FDA approved … stent Boston Scientific Corporation FDA approved WallGraft Closed-cell stent Boston Scientific Corporation … Cordis Corporation, Johnson & Johnson FDA approved Protégé Open-cell stent ev3 Inc.

2. Tool for Linking Evidence Reviews to Organizational Guideline Planning (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/linking-evidence-reviews-tools.pdf
   May 29, 2025 - Evidence-based Practice Center Portland, OR Southern California Evidence-based Practice Center-RAND Corporation

3. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
   October 27, 2009 - ; A6xx110 (20g LASER/ILLUM/ASP PROBE); OPHTHALMED LASER-ILLUMINATION Registered n/a OPTIMEDICA CORPORATION … PASCAL STREAMLINE PHOTOCOAGULATOR SE 5/4/2010 OPTIMEDICA CORPORATION PASCAL STREAMLINE PHOTOCOAGULATOR … PASCAL STREAMLINE PHOTOCOAGULATOR Registered n/a OPTIMEDICA CORPORATION PASCAL STREAMLINE Registered … TRABECULOTOME (NOT SPECIFIED) Registered n/a NEOMEDIX CORPORATION TRABECULOTOME Registered n/a OPHTHALMIC … TRABECTOME HIGH FREQUENCY GENERATOR/LP SE 5/18/2006 NEOMEDIX CORPORATION NMX-1000 SE 4/22/2004 NEOMEDIX

4. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/glaucoma_screening-apendices-11-5-10.pdf
   December 23, 2009 - MS401097-17MS722-KMS720MS721MS722 SE 7/3/1997 AUSTRALIAN BIOMEDICAL CORPORATION LTD. … FOCOMETER SE 11/22/1994 MAGNA FORTIS CORPORATION MAGNA FORTIS OPHTHALMOSCOPE DIAGNOSTIC KIT SE 9/12/ … SPAN-AID BRIDGING PILLOW SYSTEM SE 8/4/1980 TOMEY CORPORATION NON-CONTACT TONOMETER MODEL FT-1000 SE … 11/18/2008 TOMEY CORPORATION NON-CONTACT TONOMETER MODEL FT-1000 Registered n/a TOPCON INSTRUMENT … CORPORATION OF AMERICA TOPCON COMPUTERIZED TONOMETER CT-10 SE 5/18/1987 TOPCON CORP.

5. Appendix A2: FDA status of medical devices for glaucoma screening (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening-apendices-11-5-10.pdf
   December 23, 2009 - MS401097-17MS722-KMS720MS721MS722 SE 7/3/1997 AUSTRALIAN BIOMEDICAL CORPORATION LTD. … FOCOMETER SE 11/22/1994 MAGNA FORTIS CORPORATION MAGNA FORTIS OPHTHALMOSCOPE DIAGNOSTIC KIT SE 9/12/ … SPAN-AID BRIDGING PILLOW SYSTEM SE 8/4/1980 TOMEY CORPORATION NON-CONTACT TONOMETER MODEL FT-1000 SE … 11/18/2008 TOMEY CORPORATION NON-CONTACT TONOMETER MODEL FT-1000 Registered n/a TOPCON INSTRUMENT … CORPORATION OF AMERICA TOPCON COMPUTERIZED TONOMETER CT-10 SE 5/18/1987 TOPCON CORP.

6. Lysosomal-Storage-Diseases-Therapies Research-Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
   November 15, 2012 - Aldurazyme® (laronidase), Genzyme Corporation (April 2003) MPS II (Hunter disease), 1/155,000 … Fabrazyme® (agalsidase beta), Genzyme Corporation (April 2003) Gaucher Type I, overall 1/50,000 … Ceredase® (alglucerase), Genzyme Corporation (April 1991) Cerezyme® (imiglucerase), Genzyme … Corporation (May 1994) Velaglucerase® (velaglucerase alfa), Shire Human Genetic Therapies http … Myozyme® (alglucosidase alfa), Genzyme Corporation *Beutler E, Grabowski GA.

7. CER 210: Disposition of Comments for Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-210-breastfeeding-disposition-comments.pdf
   January 01, 2020 - RAND Corporation Public Reviewer 2 General Comments Dear Dr. … RAND Corporation Public Reviewer 2 General Comments Chatterji, P. and K. D. Frick (2005). … RAND Corporation Public Reviewer 2 General Comments Baker, M. and K. Milligan (2008). … RAND Corporation Public Reviewer 2 General Comments Kapinos, K. A., et al. (2017). … RAND Corporation Public Reviewer 2 General Comments Thanks for considering my suggestions.

8. Evidence-based Practice Center Systematic Review Protocol (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
   December 11, 2012 - Vascular FDA approved TREK® PTCA Abbott Vascular FDA approved Maverick® PTCA Boston Scientific Corporation … FDA approved Flextome® Cutting Boston Scientific Corporation FDA approved AngioSculpt® Cutting Angioscore … VISION™ Bare-metal stent Abbott Vascular FDA approved VeriFlex™ Bare-metal stent Boston Scientific Corporation … FDA approved CYPHER™ Drug-eluting stent Cordis Corporation/Johnson and Johnson FDA approved Endeavor … ® Drug-eluting stent Medtronic FDA approved TAXUS™/ION™ Drug-eluting stent Boston Scientific Corporation

9. Clopidogrel after Drug-Eluting Stent Implantation: Is current practice sufficient (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
   March 01, 2009 - Harrington reported receiving research grants from Boston Scientific, Cordis Corporation, Medtronic … Kandzari accepted employment with Cordis Corporation, a Johnson & Johnson Company, following the drafting … Johnson & Johnson; and he has served as a consultant for Sanofi-Aventis US LLC and Boston Scientific Corporation … Advanced Stent Technologies, Boston Scientific, Bristol-Myers Squibb, Conor Medsystems, Inc., Cordis Corporation … , Guidant Corporation, Medtronic, Sanofi-Aventis, and Terumo Medical Corporation.

10. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - Bloomfield (CT): CIGNA Health Corporation; 2014 May 15. 54 p. … MannKind Corporation: dry powder technology. [internet]. … MannKind Corporation technosphere technology. [internet]. … MannKind Corporation. … Danbury (CT): MannKind Corporation; 2014 Jun. 35 p. 82.

11. DARTNet Summary Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-ambulatory-therapeutics_research.pdf
    July 01, 2009 - (CINA), a small corporation that provides patient specific clinical decision support at the point of … CINA is a small corporation dedicated to providing patient specific clinical decision support at the … number of possible corporate models may be considered—including a 501 (c) (3), Limited Liability Corporation … remaining with the University, affiliation with or becoming a 501 (c) (3), or becoming a private corporation … capable of subcontracting to an academic institution or 501(c) (3) (e.g. a limited liability corporation

12. PULMONARY with "Discussions" in Exec Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - Silver Spring (MD): United Therapeutics Corporation; [accessed 2012 May 10]. [2 p]. … Silver Spring (MD): United Therapeutics Corporation; [accessed 2012 May 10]. [2 p]. … Silver Spring (MD): United Therapeutics Corporation; [accessed 2012 May 10]. [3 p]. … Silver Spring (MD): United Therapeutics Corporation; [accessed 2012 May 10]. [3 p]. … Silver Spring (MD): United Therapeutics Corporation; 2012 Feb 21 [accessed 2012 May 10].

13. CARDIOVASCULAR (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - CIGNA Corporation. Omnibus codes. Coverage policy number: 0504. … Bloomfield (CT): CIGNA Corporation; 2013 Feb 15. 62 p. … CIGNA Corporation. Drug list search results: Juxtapid. [internet]. … Bloomfield (CT): CIGNA Corporation [accessed 2014 Jan 29]. [1 p]. … Bloomfield (CT): CIGNA Corporation; 2014 Feb 15. 18 p.

14. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - BioEnterics Corporation. P000008. 2001 Jun 5. 6 p. 52. … Bloomfield (CT): CIGNA Corporation; 2014 May 15. 24 p. … MannKind Corporation: dry powder technology. [internet]. … MannKind Corporation technosphere technology. [internet]. … MannKind Corporation.

15. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - CIGNA Corporation. Drug list search results: bydureon. [internet]. … Bloomfield (CT): CIGNA Corporation [accessed 2012 Apr 4]. [1 p]. … ALZA Corporation. [internet]. FundingUniverse [accessed 2010 Dec 17]. [4 p]. … CIGNA Health Corporation. … Bloomfield (CT): CIGNA Health Corporation; 2012 Sep 15 [accessed 2012 Nov 14]. [7 p].

16. Template for Reports Developed (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-updates_methods.pdf
    July 01, 2011 - Research and Quality to the following Evidence-based Practice Centers: University of Ottawa, RAND Corporation … (Prepared by the University of Ottawa EPC, RAND Corporation–Southern California EPC, Oregon EPC, University … a a University of Ottawa Evidence-based Practice Center, Ottawa, Ontario, Canada b RAND Corporation–Southern … for selected CERs by comparing two methods developed at the SCEPC-based Research and Development corporation

17. PEPTIC ULCER #11 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - CIGNA Corporation. CIGNA pharmacy coverage policy number 1318: teduglutide (Gattex). … Bloomfield (CT): CIGNA Corporation; 2014 Nov 15. 3 p. … CIGNA Corporation. CIGNA pharmacy coverage policy number 1318: teduglutide (Gattex). … Bloomfield (CT): CIGNA Corporation; 2013 Oct 15. 4 p. Also available: http://www.cigna.com.

18. Migraine Protocol-Appendix 20111103 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
    November 03, 2011 - AstraZeneca Beth Israel Deaconess Medical Center Boehringer Ingelheim Pharmaceuticals Boston Scientific Corporation … The EMMES Corporation TorreyPines Therapeutics UCB, Inc.

19. THIS IS OUR TEACHER! (ppt file)
    effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
    April 01, 2006 - THIS IS OUR TEACHER! Communicating the Harms and Benefits of Medical Treatments: a look from both sides of the aisle… Prepared by michael wilkes and richard kravitz We learn about medicine through the media Press coverage is too often inaccurate, superficial, or sensationalized. Some of the most import…

20. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
    February 01, 2008 - Manufacturer FDA Approved Indication(s) Stainless Steel Greenfield® Vena Cava Filter Boston Scientific Corporation … therapy has failed or is contraindicated Titanium Greenfield® Vena Cava Filter Boston Scientific Corporation … anticoagulant therapy has failed or is contraindicated TRAPEASE® Permanent Vena Cava Filter Cordis Corporation … anticoagulant therapy has failed or is contraindicated OPTEASE® Retrievable Vena Cava Filter Cordis Corporation